A Phase i Study of Apolizumab, an Anti-HLA-DR ß-chain Monoclonal Antibody, in Patients with Solid Tumor Malignancies

Paula M. Fracasso, Sherry A. Goodner, Jonathan D. Wildi, Michael J. Naughton, Gerald P. Linette, Ramaswamy Govindan, Benjamin R. Tan, Kristie A. Blum, Gary J. Jones, Tillman E. Pearce, Daniel J. Levitt, Gerald H. Clamon

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A Phase i Study of Apolizumab, an Anti-HLA-DR ß-chain Monoclonal Antibody, in Patients with Solid Tumor Malignancies'. Together they form a unique fingerprint.

Medicine & Life Sciences